178 related articles for article (PubMed ID: 11458276)
1. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index.
Tenderenda M; Rutkowski P; Jesionek-Kupnicka D; Kubiak R
Pathol Oncol Res; 2001; 7(2):129-34. PubMed ID: 11458276
[TBL] [Abstract][Full Text] [Related]
2. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.
Elpek GO; Gelen T; Aksoy NH; Karpuzoglu T; Keles N
Pathol Oncol Res; 2000; 6(1):59-64. PubMed ID: 10749590
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.
Suzuki S; Dobashi Y; Hatakeyama Y; Tajiri R; Fujimura T; Heldin CH; Ooi A
BMC Cancer; 2010 Nov; 10():659. PubMed ID: 21118571
[TBL] [Abstract][Full Text] [Related]
4. Relationship between RGS5 expression and differentiation and angiogenesis of gastric carcinoma.
Wang JH; Huang WS; Hu CR; Guan XX; Zhou HB; Chen LB
World J Gastroenterol; 2010 Nov; 16(44):5642-6. PubMed ID: 21105200
[TBL] [Abstract][Full Text] [Related]
5. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis.
Li F; Meng G; Tan B; Chen Z; Ji Q; Wang X; Liu C; Niu S; Li Y; Liu Y
Pathol Res Pract; 2021 Jan; 217():153280. PubMed ID: 33253925
[TBL] [Abstract][Full Text] [Related]
6. Extent of spontaneous apoptosis in gastric cancer: relation to proliferative index, p53 expression, CD 34 expression and histopathological features.
Jesionek-Kupnicka D; Tenderenda M; Rutkowski P
J Exp Clin Cancer Res; 2002 Sep; 21(3):371-5. PubMed ID: 12385580
[TBL] [Abstract][Full Text] [Related]
7. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer.
Joo YE; Sohn YH; Joo SY; Lee WS; Min SW; Park CH; Rew JS; Choi SK; Park CS; Kim YJ; Kim SJ
Korean J Intern Med; 2002 Dec; 17(4):211-9. PubMed ID: 12647634
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
[TBL] [Abstract][Full Text] [Related]
9. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer.
Bădescu A; Georgescu CV; Vere CC; Crăiţoiu S; Grigore D
Rom J Morphol Embryol; 2012; 53(4):997-1005. PubMed ID: 23303024
[TBL] [Abstract][Full Text] [Related]
10. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
12. The expression of vascular endothelial growth factor and proliferative activity of cancer cells in gastric cancer.
Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Langenbecks Arch Surg; 1999 Jun; 384(3):264-70. PubMed ID: 10437615
[TBL] [Abstract][Full Text] [Related]
13. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
14. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
15. The role of SPARC protein expression in the progress of gastric cancer.
Wang L; Yang M; Shan L; Qi L; Chai C; Zhou Q; Yao K; Wu H; Sun W
Pathol Oncol Res; 2012 Jul; 18(3):697-702. PubMed ID: 22246794
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry.
Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW
Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069
[TBL] [Abstract][Full Text] [Related]
17. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
18. Well-differentiated thyroid carcinomas: p53 mutation status and microvessel density.
Goldenberg JD; Portugal LG; Wenig BL; Ferrer K; Wu JC; Sabnani J
Head Neck; 1998 Mar; 20(2):152-8. PubMed ID: 9484947
[TBL] [Abstract][Full Text] [Related]
19. Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer.
Chen CN; Cheng YM; Lin MT; Hsieh FJ; Lee PH; Chang KJ
Ann Surg; 2002 Apr; 235(4):512-8. PubMed ID: 11923607
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of angiogenesis in gastric adenocarcinoma by nestin and CD34.
Kim HS; Kang HS; Messam CA; Min KW; Park CS
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):121-7. PubMed ID: 12051629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
